Aytu Biopharma (AYTU) Liabilities from Discontinued Operations (2024)
Aytu Biopharma (AYTU) posted quarterly Liabilities from Discontinued Operations of 557000.0 for Q2 2024.
Aytu Biopharma (AYTU) Liabilities from Discontinued Operations (2024) Analysis & Trends
Aytu Biopharma (AYTU) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 557000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 557000.0; the TTM figure through Jun 2024 stood at 557000.0 (changed N/A YoY), while the FY2024 annual figure was 557000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations held at 557000.0 in Q2 2024 per AYTU's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 557000.0 in Q2 2024 and bottomed at 557000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 557,000.00 |
| Jun 30, 2024 | 557,000.00 |